Assembly Biosciences, Inc. (ASMB): Shareholders' Equity
$206.75M
As of 2025-12-31
$305.65M
As of 2026-06-30
+35.7%
3-year compound annual growth
-3.0%
5-year compound annual growth
+5.7%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $206.75M | +519.8% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $33.36M | -18.8% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $41.10M | -50.3% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $82.66M | -51.1% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $168.93M | -29.8% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $240.58M | -11.9% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $273.22M | +29.7% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $210.65M | +86.2% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $113.12M | +41.6% | 2020-03-04, Balance as of period end |
| 2016-12-31 | $79.88M | -32.7% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $118.74M | +102.7% | 2018-03-08, Balance as of period end |
| 2014-12-31 | $58.57M | +139.1% | 2017-03-02, Balance as of period end |
| 2013-12-31 | $24.49M | +37.5% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $17.81M | -48.4% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $34.53M | +197.0% | 2014-03-31, Balance as of period end |
| 2010-12-31 | $11.63M | n/m | 2014-03-31, Balance as of period end |
| 2009-12-31 | -$13.36M | n/m | 2014-03-31, Balance as of period end |
| 2008-12-31 | -$9.46M | n/m | 2014-03-31, Balance as of period end |
| 2007-12-31 | -$4.38M | n/a | 2014-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $206.75M | +519.8% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $609.98M | -23.1% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $722.17M | +7.5% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $966.90M | -8.4% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $36.98M | +13.5% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $99.01M | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $174.13M | -57.9% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $59.02M | +28.0% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $26.15M | +7.1% |
Compare ASMB, BCYC, VRDN, ABCL side by side · Screen every company in Pharmaceutical Preparations ↗